Incarceration and risk for HIV infection among injection drug users in Bangkok

Kachit Choopanya, Don Des Jarlais, Suphak Vanichseni, Dwip Kitayaporn, Philip A. Mock, Suwanee Raktham, Krit Hireanras, William L. Heyward, Sathit Sujarita, Timothy D. Mastro

Research output: Contribution to journalArticle

Abstract

Objective: To assess potential multiple relationships between incarceration and HIV infection among injecting drug users (IDUs) in Bangkok. Previous cross-sectional studies have shown strong relationships between incarceration and HIV infection but have not been able to assess potential causal pathways. Methods: Injection drug users seen at methadone treatment programs in Bangkok were screened during 1995 to 1996 for enrollment into the study. With informed consent, 1,209 seronegative IDUs were enrolled in a cohort study to determine HIV incidence and identify factors associated with incident infections. Follow-up visits were conducted every 4 months, with HIV testing and assessment of risk behaviors. Results: Overall incidence rate was 5.8 per 100 person-years (95% confidence interval [CI], 4.8-6.8) of follow-up. A four-step "injection risk" scale was constructed that included less frequent than daily injection, daily injection, daily injection with reported sharing of injection equipment, and injection while incarcerated. This scale was strongly related to HIV incidence, with incidence approximately doubling for each step in the scale. Incidence rate for follow-up periods that contained drug injection while incarcerated was 35/100 person-years at risk. In multivariate analyses, incarceration was related to incident HIV infection in multiple ways: previous incarceration and recent incarceration without drug injection, and the injection risk scale were all independently predictors of incident HIV infection. Conclusions: Incarceration is related to incident HIV infection through multiple pathways. Previous incarcerations are likely to serve as markers for unmeasured highrisk behaviors, and it is also highly likely that HIV is transmitted during periods of incarceration. Programs to reduce HIV transmission in jails and prisons, including drug abuse treatment of inmates and programs to reduce the likelihood of incarceration of IDUs, are needed urgently. Given the current diffusion of injecting drug use, of HIV infection among drug injectors, and of the common policy of incarcerating drug users, it is very likely that the problem of HIV transmission in jails and prisons is increasing in many countries throughout the world.

Original languageEnglish (US)
Pages (from-to)86-94
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2002

Fingerprint

Drug Users
HIV Infections
Injections
HIV
Incidence
Prisons
Pharmaceutical Preparations
Methadone
Risk-Taking
Informed Consent
Substance-Related Disorders
Cohort Studies
Multivariate Analysis
Cross-Sectional Studies
Confidence Intervals
Equipment and Supplies
Therapeutics

Keywords

  • AIDS
  • HIV
  • Incarceration
  • Injecting Drug Users (IDUs)
  • Thailand

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Incarceration and risk for HIV infection among injection drug users in Bangkok. / Choopanya, Kachit; Des Jarlais, Don; Vanichseni, Suphak; Kitayaporn, Dwip; Mock, Philip A.; Raktham, Suwanee; Hireanras, Krit; Heyward, William L.; Sujarita, Sathit; Mastro, Timothy D.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 29, No. 1, 01.01.2002, p. 86-94.

Research output: Contribution to journalArticle

Choopanya, K, Des Jarlais, D, Vanichseni, S, Kitayaporn, D, Mock, PA, Raktham, S, Hireanras, K, Heyward, WL, Sujarita, S & Mastro, TD 2002, 'Incarceration and risk for HIV infection among injection drug users in Bangkok', Journal of Acquired Immune Deficiency Syndromes, vol. 29, no. 1, pp. 86-94. https://doi.org/10.1097/00042560-200201010-00012
Choopanya, Kachit ; Des Jarlais, Don ; Vanichseni, Suphak ; Kitayaporn, Dwip ; Mock, Philip A. ; Raktham, Suwanee ; Hireanras, Krit ; Heyward, William L. ; Sujarita, Sathit ; Mastro, Timothy D. / Incarceration and risk for HIV infection among injection drug users in Bangkok. In: Journal of Acquired Immune Deficiency Syndromes. 2002 ; Vol. 29, No. 1. pp. 86-94.
@article{75e19658af5e4da7938bd89366a6e868,
title = "Incarceration and risk for HIV infection among injection drug users in Bangkok",
abstract = "Objective: To assess potential multiple relationships between incarceration and HIV infection among injecting drug users (IDUs) in Bangkok. Previous cross-sectional studies have shown strong relationships between incarceration and HIV infection but have not been able to assess potential causal pathways. Methods: Injection drug users seen at methadone treatment programs in Bangkok were screened during 1995 to 1996 for enrollment into the study. With informed consent, 1,209 seronegative IDUs were enrolled in a cohort study to determine HIV incidence and identify factors associated with incident infections. Follow-up visits were conducted every 4 months, with HIV testing and assessment of risk behaviors. Results: Overall incidence rate was 5.8 per 100 person-years (95{\%} confidence interval [CI], 4.8-6.8) of follow-up. A four-step {"}injection risk{"} scale was constructed that included less frequent than daily injection, daily injection, daily injection with reported sharing of injection equipment, and injection while incarcerated. This scale was strongly related to HIV incidence, with incidence approximately doubling for each step in the scale. Incidence rate for follow-up periods that contained drug injection while incarcerated was 35/100 person-years at risk. In multivariate analyses, incarceration was related to incident HIV infection in multiple ways: previous incarceration and recent incarceration without drug injection, and the injection risk scale were all independently predictors of incident HIV infection. Conclusions: Incarceration is related to incident HIV infection through multiple pathways. Previous incarcerations are likely to serve as markers for unmeasured highrisk behaviors, and it is also highly likely that HIV is transmitted during periods of incarceration. Programs to reduce HIV transmission in jails and prisons, including drug abuse treatment of inmates and programs to reduce the likelihood of incarceration of IDUs, are needed urgently. Given the current diffusion of injecting drug use, of HIV infection among drug injectors, and of the common policy of incarcerating drug users, it is very likely that the problem of HIV transmission in jails and prisons is increasing in many countries throughout the world.",
keywords = "AIDS, HIV, Incarceration, Injecting Drug Users (IDUs), Thailand",
author = "Kachit Choopanya and {Des Jarlais}, Don and Suphak Vanichseni and Dwip Kitayaporn and Mock, {Philip A.} and Suwanee Raktham and Krit Hireanras and Heyward, {William L.} and Sathit Sujarita and Mastro, {Timothy D.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1097/00042560-200201010-00012",
language = "English (US)",
volume = "29",
pages = "86--94",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Incarceration and risk for HIV infection among injection drug users in Bangkok

AU - Choopanya, Kachit

AU - Des Jarlais, Don

AU - Vanichseni, Suphak

AU - Kitayaporn, Dwip

AU - Mock, Philip A.

AU - Raktham, Suwanee

AU - Hireanras, Krit

AU - Heyward, William L.

AU - Sujarita, Sathit

AU - Mastro, Timothy D.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Objective: To assess potential multiple relationships between incarceration and HIV infection among injecting drug users (IDUs) in Bangkok. Previous cross-sectional studies have shown strong relationships between incarceration and HIV infection but have not been able to assess potential causal pathways. Methods: Injection drug users seen at methadone treatment programs in Bangkok were screened during 1995 to 1996 for enrollment into the study. With informed consent, 1,209 seronegative IDUs were enrolled in a cohort study to determine HIV incidence and identify factors associated with incident infections. Follow-up visits were conducted every 4 months, with HIV testing and assessment of risk behaviors. Results: Overall incidence rate was 5.8 per 100 person-years (95% confidence interval [CI], 4.8-6.8) of follow-up. A four-step "injection risk" scale was constructed that included less frequent than daily injection, daily injection, daily injection with reported sharing of injection equipment, and injection while incarcerated. This scale was strongly related to HIV incidence, with incidence approximately doubling for each step in the scale. Incidence rate for follow-up periods that contained drug injection while incarcerated was 35/100 person-years at risk. In multivariate analyses, incarceration was related to incident HIV infection in multiple ways: previous incarceration and recent incarceration without drug injection, and the injection risk scale were all independently predictors of incident HIV infection. Conclusions: Incarceration is related to incident HIV infection through multiple pathways. Previous incarcerations are likely to serve as markers for unmeasured highrisk behaviors, and it is also highly likely that HIV is transmitted during periods of incarceration. Programs to reduce HIV transmission in jails and prisons, including drug abuse treatment of inmates and programs to reduce the likelihood of incarceration of IDUs, are needed urgently. Given the current diffusion of injecting drug use, of HIV infection among drug injectors, and of the common policy of incarcerating drug users, it is very likely that the problem of HIV transmission in jails and prisons is increasing in many countries throughout the world.

AB - Objective: To assess potential multiple relationships between incarceration and HIV infection among injecting drug users (IDUs) in Bangkok. Previous cross-sectional studies have shown strong relationships between incarceration and HIV infection but have not been able to assess potential causal pathways. Methods: Injection drug users seen at methadone treatment programs in Bangkok were screened during 1995 to 1996 for enrollment into the study. With informed consent, 1,209 seronegative IDUs were enrolled in a cohort study to determine HIV incidence and identify factors associated with incident infections. Follow-up visits were conducted every 4 months, with HIV testing and assessment of risk behaviors. Results: Overall incidence rate was 5.8 per 100 person-years (95% confidence interval [CI], 4.8-6.8) of follow-up. A four-step "injection risk" scale was constructed that included less frequent than daily injection, daily injection, daily injection with reported sharing of injection equipment, and injection while incarcerated. This scale was strongly related to HIV incidence, with incidence approximately doubling for each step in the scale. Incidence rate for follow-up periods that contained drug injection while incarcerated was 35/100 person-years at risk. In multivariate analyses, incarceration was related to incident HIV infection in multiple ways: previous incarceration and recent incarceration without drug injection, and the injection risk scale were all independently predictors of incident HIV infection. Conclusions: Incarceration is related to incident HIV infection through multiple pathways. Previous incarcerations are likely to serve as markers for unmeasured highrisk behaviors, and it is also highly likely that HIV is transmitted during periods of incarceration. Programs to reduce HIV transmission in jails and prisons, including drug abuse treatment of inmates and programs to reduce the likelihood of incarceration of IDUs, are needed urgently. Given the current diffusion of injecting drug use, of HIV infection among drug injectors, and of the common policy of incarcerating drug users, it is very likely that the problem of HIV transmission in jails and prisons is increasing in many countries throughout the world.

KW - AIDS

KW - HIV

KW - Incarceration

KW - Injecting Drug Users (IDUs)

KW - Thailand

UR - http://www.scopus.com/inward/record.url?scp=0036151270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036151270&partnerID=8YFLogxK

U2 - 10.1097/00042560-200201010-00012

DO - 10.1097/00042560-200201010-00012

M3 - Article

VL - 29

SP - 86

EP - 94

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -